Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 101 INDUSTRY 38 OTHER_GOV 4 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Specimen Handling 67 Magnetic Resonance Spectroscopy 52 Cyclophosphamide 44 Vincristine 37 Radiotherapy 30 Radiation 30 Cisplatin 30 Carboplatin 29 Dexamethasone 27 Etoposide 26 Doxorubicin 25 Biopsy 25 daratumumab 17 Radiotherapy, Intensity-Modulated 17 Prednisone 17 Paclitaxel 16 Irinotecan 16 Cytarabine 16 durvalumab 15 Platinum 15 Gemcitabine 15 Observation 14 Methotrexate 14 Leucovorin 14 Docetaxel 14 1,2-diaminocyclohexaneplatinum II citrate 14 Lenalidomide 13 X-Rays 12 Watchful Waiting 12 Rituximab 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × toripalimab × 1 year × Clear all

NCT04918186 2026-05-12

IPROC

Canadian Cancer Trials Group

Phase 2 Recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡